ExeVir

0 followers


Rapid viral control in a world that needs it. ExeVir develops single-domain antibody-based therapies that help patients ward off viral infections. Our lead drug candidate is in accelerated development as a COVID-19 therapeutic.

Employees

1-10

Links


Org chart

Collapse
Xavier Saelens
Scientific Founder & Research Collaborator
Nico Callewaert
Scientific Founder & Research Collaborator
Viki Bockstal
Chief Scientific Officer

Board & advisors

Erica Whittaker
Board Member
Michel Kazatchkine
Board Member
Stef Heylen
Board Member, Representing Sfpim
Katja Rosenkranz
Board Observer
Joël Henneghien
Board Observer
Caroline Thielen
Board Member